Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.303
-0.075 (-19.84%)
At close: Apr 28, 2026
-11.92%
Market Cap 759.53M
Revenue (ttm) n/a
Net Income (ttm) -80.24M
Shares Out 2.01B
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 65,781,600
Average Volume 8,934,772
Open 0.295
Previous Close 0.378
Day's Range 0.242 - 0.308
52-Week Range 0.257 - 1.180
Beta 1.15
RSI 27.93
Earnings Date Apr 30, 2026

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Sector Healthcare
Founded 2015
Employees 4
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.